Legal Disclaimer
You are responsible for reading, understanding and agreeing to the National Law Review s (NLR’s) and the National Law Forum LLC s Terms of Use and Privacy Policy before using the National Law Review website. The National Law Review is a free to use, no-log in database of legal and business articles. The content and links on www.NatLawReview.com are intended for general information purposes only. Any legal analysis, legislative updates or other content and links should not be construed as legal or professional advice or a substitute for such advice. No attorney-client or confidential relationship is formed by the transmission of information between you and the National Law Review website or any of the law firms, attorneys or other professionals or organizations who include content on the National Law Review website. If you require legal or professional advice, kindly contact an attorney or other suitable professional advisor.
Abstract:
The January 29, 2021, issue of the U.S. Food and Drug Administration s (FDA) NCTR Research Highlights includes an item highlighting the National Center for Toxicological Research s (NCTR) nanotechnology-related activities in 2020.
January 29th, 2021
FDA s NCTR Highlights Its Nanotechnology-Related Activities in 2020
The January 29, 2021, issue of the U.S. Food and Drug Administration s (FDA) NCTR Research Highlights includes an item highlighting the National Center for Toxicological Research s (NCTR) nanotechnology-related activities in 2020. See https://www.fda.gov/about-fda/nctr-publications/nctr-research-highlights The activities include:
- Nanotechnology Standards: Two work items developed by the NCTR Nanotechnology Core Facility (Nanocore) staff became standards in February 2019 and January 2020 (Standard Practice for Performing Cryo-Transmission Electron Microscopy of Liposomes and Standard Test Method for Quantitative Measurement of the Chemoattractant Capaci